These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24462823)

  • 1. Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.
    Rosilio C; Ben-Sahra I; Bost F; Peyron JF
    Cancer Lett; 2014 May; 346(2):188-96. PubMed ID: 24462823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.
    Pierotti MA; Berrino F; Gariboldi M; Melani C; Mogavero A; Negri T; Pasanisi P; Pilotti S
    Oncogene; 2013 Mar; 32(12):1475-87. PubMed ID: 22665053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.
    Janjetovic K; Vucicevic L; Misirkic M; Vilimanovich U; Tovilovic G; Zogovic N; Nikolic Z; Jovanovic S; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    Eur J Pharmacol; 2011 Jan; 651(1-3):41-50. PubMed ID: 21114978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin, cancer and glucose metabolism.
    Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
    Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting AMPK in the treatment of malignancies.
    Vakana E; Altman JK; Platanias LC
    J Cell Biochem; 2012 Feb; 113(2):404-9. PubMed ID: 21928327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
    Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
    Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targets of metformin antitumor action.
    Sośnicki S; Kapral M; Węglarz L
    Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin: An anti-diabetic drug to fight cancer.
    Daugan M; Dufaÿ Wojcicki A; d'Hayer B; Boudy V
    Pharmacol Res; 2016 Nov; 113(Pt A):675-685. PubMed ID: 27720766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin as an antitumor agent in cancer prevention and treatment.
    Li D
    J Diabetes; 2011 Dec; 3(4):320-7. PubMed ID: 21631893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin, an Anti-diabetic Drug to Target Leukemia.
    Biondani G; Peyron JF
    Front Endocrinol (Lausanne); 2018; 9():446. PubMed ID: 30147674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New perspectives for metformin in cancer therapy].
    Loubière C; Dirat B; Tanti JF; Bost F
    Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and pancreatic cancer: a clue requiring investigation.
    Pollak M
    Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting AMPK: a new therapeutic opportunity in breast cancer.
    Hadad SM; Fleming S; Thompson AM
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):1-7. PubMed ID: 18343152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.
    Saini N; Yang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):133-143. PubMed ID: 29342230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
    Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
    Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspective for an old antidiabetic drug: metformin as anticancer agent.
    Leone A; Di Gennaro E; Bruzzese F; Avallone A; Budillon A
    Cancer Treat Res; 2014; 159():355-76. PubMed ID: 24114491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.